Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Published Online: 2020-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alexander Drilon•Alice T Shaw•Ann Johnson•Anna F Farago•Benjamin Besse•Brian Simmons•Byung Chul Cho•Collin M Blakely•Conor Steuer•Daniel W Bowles•Darren Sigal•Diego Tosi•Edna Chow-Maneval•Elizabeth Fox•Gary L Buchschacher•George D Demetri•Herbert H Loong•Ignacio Garrido-Laguna•John C Krauss•Jorge Nieva•Luis Paz-Ares•Lyudmila Bazhenova•Marwan Fakih•Minal Barve•Na Cui•Paul Conkling•Pilar Garrido•Robert C Doebele•Salvatore Siena•Sant P Chawla•Stephen V Liu•Susan Eng•Takashi Seto•Thomas John•Timothy R Wilson•Tobias R Overbeck•Todd Riehl•Young Kwang Chae
